Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
FOMX was delisted on the 6th of March, 2020.
64 hedge funds and large institutions have $268M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 8 closing their positions.
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
20% more capital invested
Capital invested by funds: $222M → $268M (+$45.5M)
5% more funds holding
Funds holding: 61 → 64 (+3)
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$6.62M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.17M |
| 3 |
GTC
Ghost Tree Capital
New York
|
+$1.95M |
| 4 |
Millennium Management
New York
|
+$1.92M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$942K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$2.46M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$2.17M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.35M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.27M |
| 5 |
FHAM
Folger Hill Asset Management
New York
|
-$1.16M |
FOMX Hedge Fund Activity: Q4 2016 in Review
64 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q4 2016, worth a combined $268M — up 20% from $222M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new FOMX positions and 8 closed out — a net gain of 3 holders — while 16 added to existing stakes and 22 trimmed.
The largest buyer was OppenheimerFunds, opening a new position worth an estimated $6.62M. The largest seller was Barclays, cutting an estimated $2.46M.
- 64 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q4 2016, up from 61 in Q3 2016.
- Funds reported $268M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q4 2016, up 20% quarter-over-quarter.
- 11 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q4 2016 and 8 closed out, a net change of +3 holders.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q4 2016 was OppenheimerFunds, an estimated $6.62M added.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q4 2016 was Barclays, an estimated $2.46M sold.
Based on aggregated 13F filings for Q4 2016.